Newleos Therapeutics is a clinical-stage company that develops first-in-class and best-in-class therapies to address the need for safer and more efficacious treatment options for major mental health conditions. The Company established around multiple clinical-stage programs licensed from Roche, ready for proof-of-concept studies in general anxiety (GAD), social anxiety (SAD), substance use disorders, and cognitive impairment.